Skip to content

Kantron 40 CC PDLIAB Adaptation

by Kontron Instruments, Inc. 510(k)

Active United States

510(k) K820166

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK820166 Date29 Apr 1982ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

Full name
Adaptation of Kantron 40 Cc. Pdliab
510(k) Number
FDA Product Code
DSP
Device Class
Class II
Regulation
21 CFR Part 870.3535
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Kantron 40 CC PDLIAB Adaptation is a System, Balloon, Intra-Aortic And Control, designed for temporary mechanical circulatory support. It assists cardiac function by inflating and deflating an intra-aortic balloon to modulate blood flow, improve coronary perfusion, and reduce myocardial oxygen demand during critical cardiovascular procedures or conditions.

This device is intended for single-use in controlled clinical settings, such as cardiac catheterization labs or intensive care units. It requires sterile handling and is regulated under FDA 510(k) clearance (K820166) as a Class II medical device under regulation 870.3535. Supplied as a complete system, it is not MRI-compatible and must be stored according to manufacturer instructions to maintain performance and sterility.

Other devices from Kontron Instruments, Inc.

See all devices from Kontron Instruments, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Kantron 40 CC PDLIAB Adaptation, and in which settings is it typically used?

    The Kantron 40 CC PDLIAB Adaptation is designed for temporary mechanical circulatory support by inflating and deflating an intra-aortic balloon to improve coronary perfusion, reduce myocardial oxygen demand, and assist cardiac function during critical cardiovascular procedures or conditions. It is intended for use in controlled clinical settings such as cardiac catheterization labs or intensive care units where real-time monitoring and sterile handling are essential.

  • Is this device intended for single-use or repeated use, and why does that matter?

    This device is explicitly intended for single-use only in sterile settings. This design ensures patient safety by preventing cross-contamination and maintaining device integrity, which is critical for procedures requiring precise mechanical circulatory support. Reuse could compromise sterility and performance, risking complications during cardiac interventions.

  • What storage instructions should be followed to maintain the device’s performance and sterility?

    The device must be stored according to the manufacturer’s instructions to preserve both performance and sterility. Since it is single-use and sterile upon packaging, improper storage—such as exposure to moisture, extreme temperatures, or physical damage—could compromise its functionality or integrity before use. Always adhere to the provided guidelines to ensure reliability in critical procedures.

  • Can this device be used in an MRI environment, and if not, what alternatives should clinicians consider?

    No, the Kantron 40 CC PDLIAB Adaptation is not MRI-compatible. Clinicians should avoid using it in proximity to MRI machines, as the magnetic fields could interfere with the device’s operation or pose safety risks. For patients requiring both circulatory support and MRI imaging, alternative non-MRI-compatible devices or procedural adjustments may be necessary.

  • How is the regulatory pathway for this device structured, and what does the FDA clearance indicate?

    This device holds FDA 510(k) clearance (K820166) under regulation 870.3535, classifying it as a Class II medical device. The clearance was granted through a traditional 510(k) review by the FDA’s Cardiovascular (CV) advisory committee, confirming it is *substantially equivalent* to a legally marketed predicate device. This pathway ensures it meets safety and effectiveness standards for temporary mechanical circulatory support in approved clinical applications.